Recent studies have suggested NLRP3 inflammasome/IL-1β pathway plays a critical role in the pathogenesis of type 2 diabetes mellitus [9], and other evidences have previously shown that sustained NLRP3 inflammasome activity contributes to impairing wound healing in diabetic mice [10]. This evidence concerns the gene NLRP3 and diabetes mellitus.